Request a Quote

Blog

Researcher holding a human biofluid sample

COVID-19 updates: Vaccine development, obesity worries, and plasma therapy

August 18, 2020

There’s a lot of news on COVID-19 (as always). First, some very good news: Vaccine development is progressing at a surprisingly brisk pace, with researchers arriving at phase 3 trials in six months, instead of years, raising the possibility of an approved vaccine faster than ever.

Read More

Alzheimer's patient

New experimental blood test could transform Alzheimer’s diagnosis

August 6, 2020

Researchers at Lund University in Sweden have developed a potentially breakthrough blood test for Alzheimer’s disease, a debilitating and hard-to-diagnose condition that robs patients of their memory and independent function. If and when it’s approved for general use, the new experimental test could provide a quicker, cheaper, more widely available and more definitive way to diagnose the agonizing condition.

Read More

Researchers discover hundreds of new genetic variants linked to diabetes

July 23, 2020

The largest study of its kind has demonstrated the power of biobanking, genetics and data analytics to produce new medical insights from enormous pools of patients.

Read More

Researcher Testing Biospecimen Human Sample in the Lab

Liquid Biopsy sees progress for kidney and brain cancer

July 16, 2020

Cancer often progresses under the radar, especially in its early and more treatable stages. When symptoms do arise, definitive diagnosis often requires an invasive surgical procedure. So how can we diagnose cancer earlier for more people with less effort and less discomfort? Liquid biopsy is an emerging technology aimed at addressing all of these concerns, […]

Read More

Gene therapy performed in a lab with a pipette

Promising progress for CRISPR-based sickle-cell disease therapy

July 9, 2020

In a time when good news is desperately needed, researchers are reporting very promising trial results that could yield a robust treatment for inherited blood disorders like sickle cell anemia. The news involves an experimental therapy based on CRISPR, the revolutionary gene-editing technique, and builds on successes we blogged about in December. 

Read More

People wearing masks during COVID-19 pandemic

Chasing clues to COVID-19’s particular severity in men

June 25, 2020

COVID-19 appears to be hitting men harder than women, and four months into the pandemic, the reason is still a mystery. Scientists are looking at a range of potential factors, including immune response, a protein called ACE 2, hormones, smoking and the well-documented male reticence of going to the doctor.

Read More

Male patient smiling

Promising experimental liquid biopsy for prostate cancer finds urine preferable to blood

June 18, 2020

Scientists in Russia may have found a new, more effective and less invasive way to detect prostate cancer, the second-most common cancer in men with nearly 1.3 million new cases and more than 350,000 deaths in 2018.

Read More

Coronavirus crisis takes many forms

June 10, 2020

The focus of coronavirus research is far broader than general vaccines, treatments and tests. Researchers are looking into patient genetics, early-warning systems, and the special requirements of the elderly.

Read More

COVID 19 people with masks

Convalescent plasma: How some recovered COVID-19 patients are paying back their good fortune

May 29, 2020

The concept is “convalescent plasma,” a time-honored healing art that has saved patients with diphtheria, measles and the Spanish flu going back to the late 19th century. Plasma is the colorless, liquid portion of the blood. In recovered COVID-19 patients, these plasma-based antibodies presumably provide a period of immunity and may also help recovery of actively infected patients.

Read More

Researcher in the lab

Keep your research on track

May 18, 2020

Although the coronavirus pandemic has turned our worlds upside down, it’s important for you to land on your feet. We want to help. If you work in a medical research organization, you may have or slowed or paused projects because of social distancing, or you may have pivoted to accelerate work on coronavirus treatments, tests or vaccines.

Read More

Previous   |   Next